FEATURED
Cancer biotech Chimeric soars 50pc on its debut

MELBOURNE: Champagne corks are flying for investors in emerging cancer therapy company Chimeric ... read more
Hyperion active ETF to exploit global strategy demand

BRISBANE: The Brisbane-based growth manager Hyperion is preparing to launch an active exchange ... read more